Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres











Base de données
Gamme d'année
2.
Mucosal Immunol ; 9(3): 821-833, 2016 05.
Article de Anglais | MEDLINE | ID: mdl-26813340

RÉSUMÉ

The impact of topical antiretrovirals for pre-exposure prophylaxis on humoral responses following HIV infection is unknown. Using a binding antibody multiplex assay, we investigated HIV-specific IgG and IgA responses to envelope glycoproteins, p24 Gag and p66, in the genital tract (GT) and plasma following HIV acquisition in women assigned to tenofovir gel (n=24) and placebo gel (n=24) in the CAPRISA 004 microbicide trial to assess if this topical antiretroviral had an impact on mucosal and systemic antibody responses. Linear mixed effect modeling and partial least squares discriminant analysis was used to identify multivariate antibody signatures associated with tenofovir use. There were significantly higher response rates to gp120 Env (P=0.03), p24 (P=0.002), and p66 (P=0.009) in plasma and GT in women assigned to tenofovir than placebo gel at multiple time points post infection. Notably, p66 IgA titers in the GT and plasma were significantly higher in the tenofovir compared with the placebo arm (P<0.05). Plasma titers for 9 of the 10 HIV-IgG specificities predicted GT levels. Taken together, these data suggest that humoral immune responses are increased in blood and GT of individuals who acquire HIV infection in the presence of tenofovir gel.


Sujet(s)
Antirétroviraux/usage thérapeutique , Système génital de la femme/effets des médicaments et des substances chimiques , Anticorps anti-VIH/métabolisme , Infections à VIH/traitement médicamenteux , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/immunologie , Immunoglobuline A/métabolisme , Ténofovir/usage thérapeutique , Administration par voie topique , Adulte , Femelle , Études de suivi , Système génital de la femme/immunologie , Système génital de la femme/métabolisme , Protéine de capside p24 du VIH/immunologie , Protéine d'enveloppe gp120 du VIH/immunologie , Infections à VIH/immunologie , Transcriptase inverse du VIH/immunologie , Humains , Immunoglobuline G/métabolisme , Résultat thérapeutique , Crèmes, mousses et gels vaginaux , Jeune adulte
3.
Mucosal Immunol ; 9(4): 1027-38, 2016 07.
Article de Anglais | MEDLINE | ID: mdl-26555708

RÉSUMÉ

Sex workers practicing in high HIV endemic areas have been extensively targeted to test anti-HIV prophylactic strategies. We hypothesize that in women with high levels of genital exposure to semen changes in cervico-vaginal mucosal and/or systemic immune activation will contribute to a decreased susceptibility to HIV-1 infection. To address this question, we assessed sexual activity and immune activation status (in peripheral blood), as well as cellular infiltrates and gene expression in ectocervical mucosa biopsies in female sex workers (FSWs; n=50), as compared with control women (CG; n=32). FSWs had low-to-absent HIV-1-specific immune responses with significantly lower CD38 expression on circulating CD4(+) or CD8(+) T-cells (both: P<0.001) together with lower cervical gene expression of genes associated with leukocyte homing and chemotaxis. FSWs also had increased levels of interferon-ɛ (IFNɛ) gene and protein expression in the cervical epithelium together with reduced expression of genes associated with HIV-1 integration and replication. A correlative relationship between semen exposure and elevated type-1 IFN expression in FSWs was also established. Overall, our data suggest that long-term condomless sex work can result in multiple changes within the cervico-vaginal compartment that would contribute to sustaining a lower susceptibility for HIV-1 infection in the absence of HIV-specific responses.


Sujet(s)
Lymphocytes T CD4+/physiologie , Lymphocytes T CD8+/physiologie , Infections à VIH/immunologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/physiologie , Interférons/métabolisme , Muqueuse/immunologie , Travailleurs du sexe , Adulte , Col de l'utérus/anatomopathologie , Prédisposition aux maladies , Femelle , Régulation de l'expression des gènes viraux , Humains , Tolérance immunitaire , Interféron de type I/métabolisme , Interférons/génétique , Activation des lymphocytes/génétique , Muqueuse/virologie , Sperme/immunologie , Comportement sexuel , Intégration virale/génétique , Réplication virale/génétique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE